v3.20.1
Consolidated Statement of Cash Flows
€ in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
EUR (€)
Dec. 31, 2017
EUR (€)
Condensed Cash Flow Statements, Captions [Line Items]      
Net income/loss (-) € 149,845 € (29,259) € (115,704)
Adjustment for non-cash transactions 248,027 21,753 48,301
Adjustment for items to disclose separately under operating cash flow (7,731) (4,389) (1,912)
Adjustment for items to disclose under investing and financing cash flows (5,061) (668)  
Change in working capital other than deferred income 12,698 19,922 (12,862)
Increase / decrease (-) in deferred income 2,804,202 (153,312) (65,722)
Cash generated/used (-) in operations 3,201,980 (145,953) (147,899)
Interest paid (1,158) (1,063) (273)
Interest received 7,852 4,558 1,341
Income taxes paid (57) (8) (199)
Net cash flows generated/used (-) in operating activities 3,208,617 (142,466) (147,030)
Purchase of property, plant and equipment (22,385) (10,392) (5,312)
Purchase of and expenditure in intangible fixed assets (23,300) (3,325) (2,125)
Proceeds from disposal of intangible assets   1  
Proceeds from disposal of property, plant and equipment     7
Increase in current financial investments (4,787,284)    
Interest received related to current financial investments 5,059    
Decrease in current financial investments 1,063,344    
Decrease in restricted cash     6,510
Acquisition of financial assets held at fair value through profit or loss (177) (4,559)  
Proceeds from sale of financial assets held at fair value through profit or loss 82 2,361 372
Net cash flows used in investing activities (3,764,660) (15,914) (549)
Payment of lease liabilities and other debts   (5) (65)
Payment of lease liabilities and other debts (5,091)    
Proceeds from capital and share premium increases, gross amount 960,087 296,188 363,924
Issue cost paid, related to capital and share premium increases (4,447) (15,964) (15,790)
Proceeds from capital and share premium increases from exercise of warrants 17,167 7,657 5,288
Net cash flows generated in financing activities 1,335,751 287,876 353,357
Increase in cash and cash equivalents 779,708 129,497 205,779
Cash and cash equivalents at beginning of year 1,290,796 1,151,211 973,241
Transfer to current financial investments (198,922)    
Effect of exchange rate differences on cash and cash equivalents (9,966) 10,089 (27,808)
Cash and cash equivalents at end of year 1,861,616 € 1,290,796 € 1,151,211
Warrant A | Gilead      
Condensed Cash Flow Statements, Captions [Line Items]      
Proceeds from capital and share premium increases from exercise of warrants € 368,035